Compare DERM & MKLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DERM | MKLY |
|---|---|---|
| Founded | 2014 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.1M | 244.2M |
| IPO Year | 2021 | N/A |
| Metric | DERM | MKLY |
|---|---|---|
| Price | $8.25 | $10.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | ★ 82.7K | 45.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $56,134,000.00 | N/A |
| Revenue This Year | $17.48 | N/A |
| Revenue Next Year | $55.83 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.97 | $9.88 |
| 52 Week High | $9.56 | $10.08 |
| Indicator | DERM | MKLY |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 50.51 |
| Support Level | $6.71 | $10.00 |
| Resistance Level | $8.71 | $10.06 |
| Average True Range (ATR) | 0.48 | 0.02 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 57.68 | 37.50 |
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
McKinley Acquisition Corp is a blank check company.